Skip to main content
    A

    Akari Therapeutics PLC (AKTX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $5.70
    -0.81 (-12.44%)

    Market Cap: $15.54M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Akari Therapeutics PLC (AKTX) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Akari Therapeutics (AKTX) has a latest price of $5.70 on Nov 17, 2026, 80.6% below its 52-week high of $29.32. Its price fell 73.1% over the past 12 months. The month-end price fell 99.9% over the 10 years through Oct 2026, a compound annual decline of 49.4%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $11,992.00 in Apr 2017 and its lowest $5.15 in Mar 2026, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart AKTX with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for AKTX.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 27.8%, and over 6 months it rose 52.4%. The month-end price fell 94.0% over the 3 years through Oct 2026, a compound annual decline of 60.8%.

    PeriodChange
    1 month-42.4%
    3 months-27.8%
    6 months+52.4%
    12 months-73.1%
    12 months, with dividends-73.1%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-94.0%-60.8%
    5 years-99.4%-63.8%
    10 years-99.9%-49.4%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2019, when the price rose 11.5%, and its weakest was 2025, when it fell 76.3%.

    YearCloseChange
    2026 through Oct 2026$8.24-28.7%
    2025$11.56-76.3%
    2024$48.80-60.9%
    2023$124.80-66.8%
    2022$375.92-68.7%
    2021$1,200.00-18.9%
    2020$1,480.00+5.7%
    2019$1,400.00+11.5%
    2018$1,256.00-63.7%
    2017$3,464.00-38.5%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 34.7% below its 50-day average of $8.72 and 35.8% below its 200-day average of $8.88.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$5.70
    52-week high$29.32-80.6%
    52-week low$3.02+89.1%
    50-day average$8.72-34.7%
    200-day average$8.88-35.8%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 98.2%.

    MeasureValue
    1-year beta2.33
    Largest fall, 1 year-85.6%
    Largest fall, 3 years-98.2%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About AKTX

    What is AKTX's 1-year price change?

    Akari Therapeutics's price fell 73.1% over the past 12 months. With dividends included, the 12-month total return was -73.1%.

    What is AKTX's 5-year price change?

    Akari Therapeutics's month-end price fell 99.4% over the 5 years through Oct 2026, a compound annual decline of 63.8%. These figures leave out dividends.

    What is AKTX's 52-week high and low?

    Akari Therapeutics's 52-week high is $29.32 and its 52-week low is $3.02. Its latest price of $5.70 on Nov 17, 2026 is 80.6% below the high.

    What is AKTX's beta?

    Akari Therapeutics's 1-year beta against the S&P 500 is 2.33, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 85.6%.

    Is the AKTX chart free?

    Yes. Advanced Charting for AKTX is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.